Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel

Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel

Israel implemented use of 7- and 13-valent pneumococcal vaccine in 2009 and 2010, respectively. We describe results of prospective, population-based, nationwide active surveillance of Streptococcus pneumoniae serotype 12F (Sp12F) invasive pneumococcal disease (IPD) dynamics in the 7 years after vacc...

Full description

Bibliographic Details
Main Authors: Assaf Rokney, Shalom Ben-Shimol, Zinaida Korenman, Nurith Porat, Zeev Gorodnitzky, Noga Givon-Lavi, Merav Ron, Vered Agmon, Ron Dagan, Lea Valinsky
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2018-03-01
Series:Emerging Infectious Diseases
Subjects:
Streptocococcus pneumoniae infections
12F polysaccharides Streptocococcus pneumoniae
7-valent pneumococcal vaccine
13-valent pneumococcal vaccine
emerging infectious diseases
Israel
Online Access:https://wwwnc.cdc.gov/eid/article/24/3/17-0769_article

Internet

https://wwwnc.cdc.gov/eid/article/24/3/17-0769_article

Similar Items